Attached files

file filename
EX-99.1 - CHINA-BIOTICS, INCv214474_ex99-1.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): March 14, 2011 (March 9, 2011)
 
CHINA-BIOTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)

333-110733
 
98-0393071
(Commission File Number)
 
(IRS Employer Identification No.)
 
No. 26 Orient Global Headquarter
Lane 118, Yonghe Road
Zhabei District, Shanghai 200072
People’s Republic of China
 
(Address of Principal Executive Offices)
 
(Zip Code)

(86 21) 5834 9748
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 5.07               Submission of Matters to a Vote of Security Holders.
 
On March 9, 2011, China-Biotics, Inc. (the “Company”) held its 2010 Annual Meeting of Stockholders (the “Annual Meeting”) at the Company’s executive offices at No. 26 Orient Global Headquarter, Lane 118 Yonghe Road, Zhabei District, Shanghai 200072, People’s Republic of China.
 
At the Annual Meeting, the stockholders (i) elected Mr. Song Jinan, Dr. Chin Ji Wen, Dr. Du Wen Min, and Mr. Simon Yick to serve as the Company’s directors for terms expiring on the date of the Company’s 2011 Annual Meeting of Stockholders; (ii) ratified the appointment of BDO Limited as the Company’s independent auditors for the fiscal year ending March 31, 2011; (iii) approved the Company’s 2010 Equity Incentive Plan; (iv) approved, by a non-binding vote, the compensation of the Company’s named executive officers; and (v) determined, by a non-binding vote, that a non-binding stockholder vote to approve the compensation of the Company’s named executive officers should occur every two years.
 
The following tables show the voting results of the Annual Meeting:
 
Election of Directors:
 
For
 
Withhold
Mr. Song Jinan
 
12,321,794
 
285,543
Dr. Chin Ji Wei
 
12,541,554
 
65,783
Dr. Du Wen Min
 
12,541,490
 
65,847
Mr. Simon Yick
 
12,545,837
 
61,500
 
Ratification of BDO Limited as
the Company’s independent
auditors for the fiscal year ending
March 31, 2011:
 
For
 
Against
 
Abstain
 
Broker
Non-Votes
 
  
16,492,884
  
374,828
  
62,518
  
20,631
 
Approval of the 2010 Equity
Incentive Plan:
 
For
 
Against
 
Abstain
 
Broker
Non-Votes
 
  
12,395,921
  
164,897
  
46,519
  
4,343,484
 
Approval, by a non-binding vote,
of the compensation of the named
executive officers:
 
For
 
Against
 
Abstain
 
Broker
Non-Votes
 
  
12,409,264
  
126,701
  
71,372
  
4,343,484
 
Determination, by a non-
binding vote, of the
frequency of stockholder
votes on named executive
compensation:
 
Every Year
 
Every Two
Years
 
Every
Three
Years
 
Abstain
 
Broker
Non-Votes
 
  
1,553,867
  
9,209,574
  
1,817,153
  
20,631
  
4,349,596
 
Item 9.01
Financial Statements and Exhibits.
 
(d)  Exhibits
 
Exhibit
Number
 
Description
99.1
 
Press release, dated March 14, 2011, announcing the voting results of the Annual Meeting
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
China-Biotics, Inc.
     
Date: March 14, 2011
By:
/s/ Song Jinan
     
   
Song Jinan
     
   
Chief Executive Officer, President,
   
Treasurer and Secretary